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A Novel Cellular Phenotype for Familial
Hypercholesterolemia due to a Defect
in Polarized Targeting of LDL Receptor
are well understood (Matter and Mellman, 1994; Drubin
and Nelson, 1996). In many cases, basolateral targeting
involves specific cytoplasmic domain signals. In Madin-
Darby canine kidney (MDCK) cells, either of two such
signals can target LDLR from the Golgi complex or from
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endosomes to the basolateral membrane: (1) a low ca-333 Cedar Street
pacity determinant partly colinear with the receptor’sPO Box 208002
signal for endocytosis and (2) a high capacity determi-New Haven, Connecticut 06520
nant unrelated to endocytosis signals (Matter et al.,2 Department of Cell Biology
1992). These signals are at sites proximal and distal toJohns Hopkins University School of Medicine
the membrane, respectively, but both depend on critical725 North Wolfe Street
tyrosine residues. Additionally, a glycine residue adja-Baltimore, Maryland 21205
cent to the tyrosine residue is required for optimal func-
tion of the distal signal, as is a patch of acidic residues
downstream from the tyrosine (Matter et al., 1994). Inter-Summary
estingly, the same glycine residue important for polar-
ized sorting in MDCK cells is replaced by aspartic acidBasolateral targeting of membrane proteins in polar-
in FH patients harboring the FH-Turku (G823D) allele, aized epithelial cells typically requires cytoplasmic do-
common FH gene in the Finnish population (Koivisto etmain sorting signals. In the familial hypercholesterol-
al., 1995).emia (FH)-Turku LDL receptor allele, a mutation of
Hepatocytes are distinguished from other well-stud-glycine 823 residue affects the signal required for ba-
ied epithelial cells in the way they establish and maintainsolateral targeting in MDCK cells. We show that the
the polarized distribution of plasma membrane compo-mutant receptor is mistargeted to the apical surface
nents. Based on observations in rat liver and in thein both MDCK and hepatic epithelial cells, resulting
hepatocyte-like WIF-B cell line, endosomes appear toin reduced endocytosis of LDL from the basolateral/
be the predominant sorting site for both internalized andsinusoidal surface. Consequently, virally encoded mu-
newly synthesized proteins in hepatocytes (Mostov ettant receptor fails to mediate cholesterol clearance in
al., 1992; Bartles et al., 1987; Ihrke et al., 1998). Thus,LDL receptor-deficient mice, suggesting that a defect
most apical and basolateral proteins are not sorted uponin polarized LDL receptor expression in hepatocytes
exit from the trans-Golgi network (TGN). They are in-underlies the hypercholesterolemia in patients harbor-
stead transported together to the basolateral surfaceing this allele. This evidence directly links the patho-
where they are internalized and then directed from endo-genesis of a human disease to defects in basolateral
somes to their final destinations. MDCK cells, in con-targeting signals, providing a genetic confirmation of
trast, utilize a direct sorting pathway from the TGN tothese signals in maintaining epithelial cell polarity.
the apical membrane (Matter and Mellman, 1994; Keller
and Simons, 1997).Introduction
Hepatocytes are further distinguished by the fact that
they do not express an epithelial cell-specific subunitRegulation of plasma low density lipoprotein (LDL) con-
(1B) of the AP-1 clathrin adaptor complex (Ohno et al.,centrations takes place primarily in the liver, the major
1999). AP-1 adaptors containing 1B are essential for
site of both LDL production and catabolism. The ability
decoding basolateral targeting signals in receptors such
of the liver to maintain whole body cholesterol homeo-
as LDLR in the TGN of kidney epithelia (Fo¨lsch et al.,
stasis is in turn greatly dependent on the activity of 1999). Hepatocytes may nevertheless recognize the
specific LDL receptors (LDLR) that mediate the endo- same array of targeting signals, as proteins that are
cytic uptake of LDL. This fact is best illustrated by the basolateral in other epithelia are generally sinusoidal in
decreased hepatic clearance of plasma LDL in patients liver (Matter and Mellman, 1994). Moreover, deletion of
with familial hypercholesterolemia (FH), a disease caused large segments of the LDLR cytoplasmic domain that
by genetic defects in the LDLR pathway (Hobbs et al., contain known basolateral targeting signals result in api-
1992). The resultant high LDL levels lead to premature cal expression in the livers of transgenic mice (Yokode
atherosclerosis and coronary heart disease. Conse- et al., 1992). Yet, given the differences in sorting path-
quently, sufficient numbers of functional LDLRs must be ways and adaptor expression, there may be important
expressed on the plasma membrane to maintain normal differences in the signals used by hepatocytes versus
cholesterol levels. Furthermore, to promote removal of other types of epithelial cells.
LDL from plasma, the receptors must be expressed in We investigated the cellular phenotype associated
a polarized fashion at the hepatocyte sinusoidal surface. with the FH-Turku allele to determine if a mutation in an
The basic strategies governing the ability of epithelial LDLR basolateral targeting signal could manifest itself
cells to selectively target membrane and secretory pro- with severe hypercholesterolemia due to the missorting
teins to apical or basolateral plasma membrane domains of otherwise functional receptors. Our data indeed dem-
onstrate that a mutation in a critical glycine 34 residue
within the receptor’s cytoplasmic tail domain affects3 Correspondence: ira.mellman@yale.edu
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Figure 1. Functional Expression of Wild-
Type and G34D Mutant LDLR in MDCK Cells
(A) LDLR-G34D is expressed on the apical
surface of MDCK cells. Filter-grown MDCK
cells were microinjected with expression
plasmids encoding either the wild-type (left)
or LDLR-G34D mutant (right) together with
the VSVGts045-GFP plasmid to identify in-
jected cells. After expression of 2 hr at 37C
and another 2 hr at 31C, the cells were fixed
and stained for cell surface LDLR expression.
Vertical cross-sections (z-axis) of representa-
tive cells are shown. LDLR staining on baso-
lateral and apical membrane domain is indi-
cated by the arrow and the arrowhead,
respectively. Green (VSVGts045-GFP), Red
(LDLR).
(B) LDLR-G34D affects selectively polarized
targeting without affecting endocytosis of
DiI-LDL. Filter-grown MDCK cells were in-
fected with recombinant adenoviruses en-
coding either the wild-type LDLR (left) or
LDLR-G34D mutant (right) and analyzed for
the uptake of DiI-labeled LDL. Apical endocy-
tosis (top panels) was determined 24 hr later
by continuous uptake of DiI-LDL (20 g/ml)
from the apical media for 30 min at 37C.
Endocytosis from the basolateral side (bot-
tom panels) was determined 48 hr postinfec-
tion by binding of DiI-LDL (10 g/ml) on the
basolateral surface at 4C for 90 min followed
by 15 min incubation at 37C. For endocytosis
assays at the basolateral surface, cells were
grown on filters with 3 m pores to optimize
access to LDL particles. Insets show lower
magnification views of the negative panels to
demonstrate the presence of expressing cells
(green) that failed to internalize the ligand
from the indicated plasma membrane
domain.
(C) LDLR-G34D is missorted within the secre-
tory pathway in MDCK cells. Stable cell lines
expressing either the wild-type or the G34D
mutant were generated and grown on perme-
able filter supports. LDLR polarity was ana-
lyzed by vectorial antibody binding assay in
which 125I-labeled C7 IgG was added either
to the apical or basal media. Replacement of
the glycine 34 residue by aspartic acid (G34D)
resulted in a highly increased apical polarity
(up to 67% apical) as compared to the wild-
type receptor (up to 94% basolateral). Data
shown represents meansSE of four individ-
ual experiments each performed in triplicate.The surface distribution of newly synthesized LDLR was analyzed in the same stably transfected
cell lines by domain-specific biotinylation as performed previously (Matter et al., 1992).
polarized targeting of the LDLR in both the secretory acid mutation in FH-Turku (G34D) affected polarized
sorting on its own. Previous work examined only a gly-(MDCK) and endocytic (MDCK, WIF-B) pathways, and
underlies the metabolic abnormality resulting in reduced cine to alanine substitution at this position in combina-
tion with a tyrosine to alanine mutation at position 18liver LDL clearance in vivo.
to inactivate a second basolateral targeting signal in a
membrane proximal position (Matter et al., 1994). TheResults
double mutant markedly increased apical expression
(55% for the Y18AG34A double mutant as opposed toThe G34D FH-Turku Mutation Affects Basolateral
Targeting in MDCK Cells only 5%–15% for the Y18A single mutant) (Hunziker et
al., 1991; Matter et al., 1994).The FH-Turku mutation affects a conserved glycine-
tyrosine (GY) motif at positions 34 and 35 of the LDLR We expressed wild-type and FH-Turku receptors in
polarized MDCK cells by cDNA microinjection or infec-cytoplasmic domain (Koivisto et al., 1995). Since these
residues are essential for efficient basolateral targeting tion using recombinant adenoviruses. When injected
cells were analyzed by immunofluorescence confocalin MDCK cells, we first asked if the glycine to aspartic
FH due to a Defect in Polarized Targeting
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Figure 2. LDLR-G34D Is Mistargeted to the Bile Canalicular (apical) Domain in WIF-B Cells
Polarized WIF-B cells were comicroinjected with expression plasmids encoding either the wild-type LDLR (A) or LDLR-G34D mutant (B) and
the VSVGts045-GFP plasmid. After 4 hr of expression at 37C, the cells were fixed in PFA/methanol and double-stained for the localization
of LDLR and the endogenously expressed APN on the bile canalicular membrane. Green (VSVGts045-GFP), Red (LDLR), Blue (APN).
microscopy, the mutant receptor (LDLR-G34D) was The G34D Mutation Results in Mistargeting
of LDLR to the Apical Surface in Hepaticfound mistargeted to the apical surface, while the wild-
type LDLR (LDLR-WT) was expressed only on basolat- WIF-B Cells
Given the differences in sorting pathways between kid-eral surface (Figure 1A). Identical results were obtained
using the corresponding recombinant adenoviruses (not ney epithelia and hepatocytes, it cannot be assumed
that a mutation affecting polarity in MDCK cells willshown). Although qualitative, these results demon-
strated that substitution of an aspartic acid for the gly- exhibit the same phenotype in hepatocytes. Thus, to
determine if glycine 34 was required for basolateral tar-cine at position 34 effectively reversed the polarity of
the LDLR. geting in hepatocytes, we analyzed the localization of
the LDLR in polarized hepatic WIF-B cells (Ihrke et al.,We next confirmed that the G34D mutation had no
effect on LDLR-mediated endocytosis. MDCK cells in- 1993).
WIF-B cells were microinjected with an LDLR expres-fected with a recombinant adenovirus encoding wild-
type LDLR were capable of internalizing fluorescent LDL sion plasmid and analyzed by confocal immunofluores-
cence microscopy; as before, VSVGts045-GFP was(DiI-LDL) from the basolateral but not from the apical
surface (Figure 1B). Cells expressing the LDLR-G34D coinjected to mark expressing cells. WIF-B cells ex-
pressing wild-type LDLR exhibited a strikingly polarizedwere also able to internalize DiI-LDL, but as expected,
only from the apical side. These results were confirmed pattern in which the receptor was limited to the basolat-
eral surface of the cells (Figure 2A). The receptor wasby quantitative binding and uptake assays of 125I-labeled
anti-LDLR antibody (C7 IgG) using transiently trans- excluded entirely from the bile canalicular domain that
forms between adjacent cells, illustrated by its nonover-fected nonpolarized CHO cells (internalization index of
1.7 for wild-type versus 1.9 for LDLR-G34D; internaliza- lapping distribution with the endogenous apical marker
aminopeptidase N (APN). In contrast, the G34D mutanttion index represents internalized/bound radiolabel at
15 min [Davis et al., 1986]). Similar results were obtained was found predominantly at the bile canalicular domain
where it colocalized with APN (Figure 2B). Relativelyin stably expressing MDCK cells grown on plastic or
filters (not shown). little staining was found at the basolateral surface. The
small amount of basolateral LDLR would be consistent,We also confirmed that the mislocalization of the
G34D mutant reflected its missorting in the TGN. For however, with the predicted transient residence of newly
synthesized apical proteins at the basolateral domainthese experiments, stable cell lines expressing the mu-
tant or wild-type forms of the receptor were generated in hepatocytes.
Indeed, we next demonstrated directly that the G34Dand then analyzed by pulse-chase radiolabeling fol-
lowed by vectorial biotinylation to determine the kinetics mutant was transcytosed across the WIF-B cells from
basolateral to the apical surface. For these experiments,of appearance of receptors at the apical or basolateral
surfaces. As has already been well established for other WIF-B cells were infected with recombinant adenovir-
uses encoding either the wild-type or the G34D mutantLDLR targeting mutants (Matter et al., 1993, 1994), newly
synthesized LDLR-G34D reached the apical surface di- receptor, and the cells allowed to bind the anti-LDLR anti-
body C7 at 4C. The cells were then washed and warmedrectly from the TGN, i.e., without first having to appear
at the basolateral surface; wild-type LDLR appeared to 37C, and the fate of the antibody-labeled receptors
monitored by immunofluorescence. Although cells ex-directly and almost exclusively at the basolateral side
(Figure 1C). pressing both wild-type and mutant receptors initially
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Figure 3. LDLR-G34D Reaches the Apical
Domain by Transcytosis
WIF-B cells were infected with adenoviruses
encoding the wild-type LDLR (A) or LDLR-
G34D (B). After 24 hr of expression, the cells
were placed on ice and allowed to bind C7
IgG for 30 min before washing and culture at
37C in antibody-free medium. At the indi-
cated times, the cells were fixed with PFA/
methanol and stained for the distribution of
C7 IgG-labeled LDLR and endogenously ex-
pressed canalicular marker APN. In infected
cells, C7 IgG bound to LDLR-G34D, but not
wild-type LDLR, began to appear at the apical
surface after just 10–15 min of uptake. C7 IgG
did not bind to uninfected cells. Red (LDLR),
Blue (APN).
exhibited only basolateral labeling (0 min), cells express- the fluorescent ligand (Figure 4). This presumably re-
flects the fact that the mutant receptors, although capa-ing the G34D mutant began to show apical staining after
just 10–15 min of endocytosis (Figure 3). In contrast, ble of LDL endocytosis (e.g., Figure 1B), were localized
largely to the apical domain, which was sequestered bylabeling of the antibody bound to wild-type receptors
was restricted either to the basolateral plasma mem- junctional complexes from the growth medium. Appar-
ently, the relatively small amount of mutant receptor inbrane or to intracellular vesicles and never reached the
APN-positive apical domain. At longer chase times (45 transient residence at the basolateral surface was not
sufficient to achieve significant amounts of DiI-LDLmin), the remaining labeled vesicles in the wild-type-
expressing cells were concentrated in the apical cyto- uptake.
plasm just below the bile canaliculus, a location reminis-
cent of apical recycling vesicles in MDCK and Caco-2
cells (Apodaca et al., 1994; Knight et al., 1995; Sheff et Hepatocytes Rely Predominantly on the LDLR
Distal Basolateral Targeting Signalal., 1999; Tuma et al., 1999). We suspect that C7 bound to
wild-type LDLR traced the normal basolateral recycling The LDLR cytoplasmic domain contains two distinct
basolateral targeting signals, the first in a membranepathway of the receptor. In any event, these results
demonstrated that the G34D mutation caused apical proximal position and dependent on tyrosine 18, the
second in a more distal COOH-terminal position andexpression largely due to missorting during endocy-
tosis. dependent on glycine 34 and tyrosine 35. In MDCK cells,
the distal signal is dominant in that the elimination ofWe next asked if the differential localization of the
wild-type and mutant LDLRs in polarized WIF-B cells tyrosine 18 by itself has little effect on basolateral polar-
ity at moderate expression levels in stably transfectedaffected the ability of each receptor to mediate LDL
uptake. Although WIF-B cells expressing wild-type cells (Matter et al., 1992). Since this tyrosine residue is
critical for LDLR endocytosis (Davis et al., 1986, 1987),LDLR (following infection with a recombinant adenovi-
rus) exhibited significant internalization of DiI-LDL, cells we next examined its role in determining LDLR polarity
in hepatocytes given the central role of endocytosis andexpressing the LDLR-G34D accumulated very little of
FH due to a Defect in Polarized Targeting
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ing was also seen in intracellular vesicles, presumably
reflecting the slow basal rate of internalization that oc-
curs even in the absence of a coated pit signal. We next
determined the distribution of LDLR double mutant in
which the tyrosine 18 mutation was combined with a
mutation in glycine 34 (Y18AG34D), a receptor which
was not only endocytosis defective, but also devoid of
all basolateral targeting information. As shown in Figure
5B, the LDLR-Y18AG34D was expressed at the apical
surface to an extent similar to that seen for the G34D
mutant alone (compare with Figure 2B). Given the ab-
sence of a functional coated pit signal, we next asked
if the LDLR-Y18AG34D double mutant nevertheless
reached the apical surface by the indirect route, follow-
ing transcytosis from the basolateral surface. Indeed,
by monitoring the fate of the C7 anti-LDLR antibody
bound at the basolateral surface of these cells, LDLR-
Y18AG34D mediated C7 IgG transcytosis, albeit more
slowly than the C34D single mutant (45 min versus 10-
15 min) (Figure 6B versus Figure 3B). A mutant receptor
lacking only the coated pit localization domain but re-
taining the distal basolateral targeting signal failed to
Figure 4. Polarized Distribution of the LDLR Parallels the Endocyto- mediate basolateral to apical transcytosis of C7 IgG
sis of DiI-LDL from the Basolateral Surface in WIF-B Cells
(Figure 6A).
WIF-B cells were infected with recombinant adenoviruses encoding
Thus, hepatocytes appear to rely predominantly, if noteither the wild-type LDLR (top) or the LDLR-G34D mutant (bottom).
exclusively, on the distal glycine 34-containing basolat-After 24 hr of infection, the cells were assayed for the uptake of DiI-
eral targeting signal. Accordingly, we found that theLDL (2 g/ml) in the growth medium by a 30 min incubation at 37C.
The cells were washed with PBS, fixed with PFA/methanol, and effect of G34D mutation was dominant with respect to
stained for LDLR expression. Red (DiI-LDL), Blue (LDLR). the equilibrium distribution of the receptor.
Mistargeting of the LDLR in Liver Causesendosomal recycling in sorting apical from basolateral
membrane proteins. Defective LDL Clearance and Underlies
the Metabolic Abnormality in FHWe first investigated the effect of a tyrosine 18 (Y18A)
mutation on LDLR polarity in microinjected or adenovi- To demonstrate directly that a defect in polarized tar-
geting of the LDLR produces a clinical picture of severerus-infected WIF-B cells. As expected, these endocyto-
sis-defective receptors, which possessed only the distal hypercholesterolemia, we extended our cell culture ob-
servations by overexpressing the same LDLR recombi-basolateral targeting signal, were expressed predomi-
nantly at the basolateral surface (Figure 5A). Some label- nant adenoviruses in vivo using LDLR//APOBEC-1/
Figure 5. G34-Containing Basolateral Targeting Signal Is Dominant over the Clathrin-Mediated Endocytosis Signal
Polarized WIF-B cells were microinjected with expression plasmids encoding the endocytosis-defective mutants LDLR-Y18A (A) or LDLR-
Y18AG34D (B) together with the VSVGts045-GFP plasmid. The LDLR expression was analyzed as described in Figure 2. Green (VSVGts045-
GFP), Red (LDLR), Blue (APN).
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mice, a mouse model of human FH (Powell-Braxton et faces was also observed, but these receptors were un-
able to mediate physiologically significant amounts ofal., 1998). Four different viruses were used, encoding
LDLR wild-type, as well as G34D, Y18A, and Y18AG34D LDL uptake (see below). Therefore, the sinusoidal stain-
ing may represent LDLR expression in cells lining themutants.
We injected 5  109 pfu of each of the adenovirus- sinusoids, such as endothelial, Kupfer, or other perisinu-
soidal cells which are susceptible to infection by recom-encoded transgenes intravenously into LDLR//
APOBEC-1/ mice. This dose resulted in a uniform ex- binant adenoviruses (Yu et al., 2000).
The fact that the FH-Turku LDLR G34D was expressedpression of virally encoded receptors in a large majority
of hepatocytes 4–10 days postinjection, as demon- largely at the apical surface suggested that it might not
be accessible to plasma LDL and thus might be unablestrated by immunofluoresence microscopy of frozen
liver sections stained for the human LDLR (blue) and to mediate efficient clearance of plasma cholesterol. We
therefore assessed the ability of wild-type versus mutantendogenous APN (red) (Figure 7A).
To assess the polarity of LDLR expression, higher LDLR to lower the steady-state cholesterol levels in
LDLR//APOBEC-1/ mice. It has been previouslymagnification images were analyzed. As previously re-
ported (Herz and Gerard, 1993; Ishibashi et al., 1993), shown that adenovirus-mediated gene transfer of the
wild-type LDLR results in an acute reversal of hypercho-adenovirus-encoded wild-type human LDLR was ex-
pressed on the sinusoidal surface of hepatocytes, to- lesterolemia in LDLR knockout mice (Ishibashi et al.,
1993) and also accelerates cholesterol clearance in nor-gether with some staining on the lateral surfaces (Figure
7B, upper panels [a]). Importantly, the receptor was not mal mice (Herz and Gerard, 1993). We similarly found
that the plasma steady-state total cholesterol levels indetected at the bile canalicular membrane, visualized
by staining for APN or a second apical marker dipeptidyl the LDLR//APOBEC-1/ mice intravenously injected
with 5  109 pfu of the wild-type LDLR recombinantpeptidase IV (DPPIV; arrowheads). Some DPPIV staining
was also present sinusoidally, reflecting its expression virus decreased drastically upon overexpression of the
virally encoded LDLR. Four days after virus infection,by sinusoidal lining cells (arrows; see legend). The distri-
bution of the endocytosis-defective form of the LDL the total plasma cholesterol in a cohort of six mice was
reduced by up to 88% (average decrease of 78  3(Y18A) resembled that of the wild-type LDLR (not
shown). SEM%), and the effect of the transgene expression on
reducing cholesterol levels persisted in individual miceThe staining pattern of the LDLR-G34D mutant trans-
gene was different from that of the wild-type receptor. for at least 10 days (Figure 8A).
In contrast, adenovirus-mediated expression of theHuman LDLR was now distinctly visible at bile canalicu-
lar surface as indicated by its colocalization with DPPIV G34D mutant had little effect on steady-state cholesterol
levels (Figure 8A). Although a small decrease was ob-(arrowheads in Figure 7B, lower panels [b]). Similar re-
sults were obtained using three different antibodies to served at day 4 in a few mice, this possibly reflected
high viral overexpression in general that might have re-LDLR (see Experimental Procedures) and also using liv-
ers expressing the LDLR-Y18AG34D double mutant (not sulted in some uptake by extrahepatic or nonparenchy-
mal liver cells (e.g., Kupfer cells, see above). More impor-shown). Some mutant LDLR staining at sinusoidal sur-
Figure 6. Apical Localization of the LDLR-Y18AG34D Requires Basolateral Endocytosis
WIF-B cells expressing virally encoded endocytosis-defective mutants LDLR-Y18A (A) or LDLR-Y18AG34D (B) were assayed for basolateral-
to-apical transcytosis of the C7 IgG-labeled LDLR as described in Figure 3. While the absence of a functional clathrin-coated pit localization
signal alone (LDLR-Y18A) had no effect on LDLR polarity, the cells expressing LDLR-Y18AG34D began to exhibit apical staining after 45
min of endocytosis. Red (LDLR), Blue (APN).
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Figure 7. Expression of the Virally Encoded Wild-Type and Mutant LDLRs in Mouse Liver In Vivo
LDLR//APOBEC-1/ mice were injected with 5  109 pfu of the indicated adenovirally encoded LDLR and perfused 4–5 days postinjection.
Expression of LDLR was analyzed in frozen liver sections by indirect immunofluoresence. Low power survey view (A) of mouse liver sections
stained with a monoclonal C7 IgG to LDLR (blue) demonstrated comparably efficient expression of the virally encoded wild-type and mutant
LDLRs in the majority of hepatocytes. Bile canaliculi were stained for the endogenously expressed apical protein APN (red). High power view
(B) of liver sections from mice expressing either the virally encoded wild-type LDLR (a/top) or the LDLR-G34D (b/bottom), stained using a
rabbit polyclonal antibody to bovine LDLR (Yokode et al., 1992) (red). Bile canaliculi (arrowheads) were stained with a monoclonal antibody
against DPPIV (blue) that also stains the hepatic endothelium lining the sinusoids (arrows). The wild-type LDLR was expressed exclusively
on the sinusoidal surface of hepatocytes while the G34D mutant was also detectable from the bile canalicular surface. Scale bar represents
10 m. (a: wild-type LDLR; b: LDLR-G34D; red [LDLR], blue [DPPIV]).
tantly, when the entire cohort of 17 mice was analyzed any time point. Similar results were obtained in mice
infected with LDLR mutants affecting the coated pitwith all time points combined, total plasma cholesterol
levels remained similar to preinjection levels (average localization signal alone (Y18A) or in combination with
the glycine 34 mutation (Y18AG34D). Both endocytosis-91  8 SEM% of preinjection levels). Moreover, when
cholesterol levels were directly compared in age- and defective receptors were unable to reduce starting cho-
lesterol levels. At days 4–10, cholesterol levels in micesex-matched littermates used within this series of ex-
periments, only the adenovirus encoding the wild-type expressing the Y18A mutant remained at 98% of prein-
jection levels (14 SEM%, n  5 mice); at days 4–7,LDLR was able to reverse the hypercholesterolemia at
Cell
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G34D transgene. Thus, functional LDLR expression at
the sinusoidal surface was disrupted by the G34D mu-
tation.
Taken together, our results on the localization and
function of LDLR both in cell culture and in vivo provide
direct evidence that a mutation affecting the glycine 34
residue produces a receptor that cannot promote the
proper plasma LDL clearance by the liver due to its
altered polarity of expression in hepatocytes. Conse-
quently, mistargeting of the LDLR is likely to account
for hypercholesterolemia in patients harboring the FH-
Turku allele.
Discussion
Systematic analysis of LDLR phenotypes associated
with various FH alleles has revealed a range of mutations
that directly or indirectly reduce the ability of the recep-
tor to mediate endocytosis of plasma lipoproteins con-
taining apo B-100 and/or apo E. To date, mutations have
been described that diminish ligand binding, block the
synthesis or surface delivery of LDLR, or prevent the
internalization or recycling of otherwise functional re-
ceptors (Hobbs et al., 1992). Study of mutant LDLRs
has been critical to developing current concepts in cell
biology, particularly in the case of receptor-mediated
endocytosis (Davis et al., 1986). Our work has added an
Figure 8. LDLR-G34D Does Not Correct the Metabolic Abnormality additional element by showing that the FH phenotype
in LDLR//APOBEC-1/ Mice can also result from a defect in polarized targeting in
(A) Expression of mutant LDLR fails to correct hypercholesterolemia epithelial cells. By affecting an amino acid residue es-
in LDLR//APOBEC-1/ mice. Steady-state total plasma choles- sential for proper basolateral transport, the FH-Turku
terol levels (mg/dl) were measured before and at the indicated day
allele has emphasized the functional importance ofafter the injection of 5  109 pfu of either the adenovirally encoded
LDLR expression at the sinusoidal surface of hepato-wild-type LDLR or the LDLR-G34D mutant. The total cholesterol
cytes. Moreover, the fact that the same conserved resi-remaining in the plasma was plotted as a percentage of total choles-
terol prior to injection. Squares (blue) denote the mice injected with due is required for basolateral expression in both hepa-
the adenovirus encoding the wild-type LDLR, diamonds (red) denote tocytes and MDCK cells strongly suggests that both
the mice injected with the adenovirus encoding the LDLR-G34D. cell types make use of common targeting signals; this
(B) LDLR-G34D fails to mediate rapid clearance of intravenously despite their use of different pathways for polarized pro-
injected 125I-C7 IgG from plasma. Six mice expressing either the
tein sorting and transport.wild-type (blue) or LDLR-G34D mutant (red) were studied in sex-
We used several independent experimental ap-matched littermate pairs (identical symbols) for the plasma clear-
proaches to show that the G34D mutation is responsibleance of 125I-labeled (7.5  106 cpm) anti-LDLR antibody C7 IgG
(Huettinger et al., 1984). Four days postinjection, the mice were for mistargeting the LDLR from the basolateral to the
anesthetized, 125I-C7 IgG was injected into the retro-orbital sinus, apical membrane domain in hepatocytes. Consequently,
and blood was collected from the contralateral sinus at the indicated the mutant receptor fails to mediate a physiologically
intervals. The trichloroacetic acid-precipitable radioactivity re- relevant increase in LDLR activity on the sinusoidal
maining in plasma was plotted as a percentage of the radioactivity
membrane, resulting in retarded LDL clearance in vivo.in a plasma sample obtained shortly (3 min) after injection. For each
Although we have not excluded the possibility that someaverage curve, two LDLR//APOBEC-1/ mice (circles, diamonds)
mutant LDLR can follow the direct pathway to the apicaland one wild-type mouse (squares) were studied.
surface, we found that the predominant expression of
the G34D mutant on the apical surface was largely due
the Y18AG34D mice remained at 93% of control (10 to basolateral to apical endocytosis. Thus, the mutant
SEM%, n  4 mice). receptor appears to be transported from the TGN to the
To directly evaluate the effect of G34D mutation on sinusoidal plasma membrane along with other basolat-
cholesterol clearance, we next analyzed the clearance eral proteins. After internalization, the absence of a func-
rate of intravenously administered 125I-labeled C7 IgG in tional basolateral targeting signal would render less effi-
mice overexpressing either the wild-type LDLR or the cient the recycling of the G34D mutant back to the
G34D mutant. The clearance rate of intravenously ad- sinusoidal domain; instead, it would be transcytosed to
ministered 125I-labeled C7 IgG was rapid in mice express- the apical surface in a fashion analogous to the well-
ing the wild-type transgene, with 40% of injected dose characterized polymeric immunoglobulin receptor
removed from plasma between 3 and 10 min after the (Mostov, 1994). Although a direct pathway to the apical
radioactive bolus (Figure 8B). Consistent with the lack surface has recently been reported in hepatocytes, it
of effect on steady-state cholesterol levels, the rate of seems thus far to be used only by certain polytopic
disappearance of intravenously administered 125I-C7 IgG canalicular membrane proteins (e.g., ABC transporters)
(Kipp and Arias, 2000).was delayed markedly in mice expressing the LDLR-
FH due to a Defect in Polarized Targeting
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The question of polarized transport in hepatocytes Turku allele manifest with severe hypercholesterolemia
has re-emerged as an important issue since hepato- provides the most reliable and by far the most physiolog-
cytes do not express the epithelial cell-specific clathrin ically relevant demonstration of the importance of GY-
AP-1 adaptor subunit 1B (Ohno et al., 1999). In other based targeting signals in the maintenance of LDLR
epithelia, 1B-containing AP-1B complexes have been polarity. While there are other clinical disorders which
shown to be required for basolateral transport of pro- are associated with alterations in polarity, these do so
teins such as LDLR by directly interacting with the re- by affecting mechanisms which are quite different from
ceptor’s basolateral targeting signals (Fo¨lsch et al., and less well understood than that described here. For
2001). In liver, due to a predominant reliance on indirect example, overall defects in vesicular targeting may un-
endosomal sorting, it is possible that AP-1A or AP-2 derlie disorders such as autosomal dominant polycystic
complexes substitute functionally for AP-1B. Conceiv- kidney disease (Charron et al., 2000) and microvillus
ably, AP-1A may function in association with a nonadap- inclusion disease affecting intestinal epithelia (Ameen,
tor component that modifies its activity in a fashion 2000); the mechanisms responsible for these pheno-
analogous to the action of PACS-1 or TIP47 in the trans- types are unknown. Another example is a cystic fibrosis
port of proteins between the TGN and endosomes (Diaz allele exhibiting a large deletion that removes a segment
and Pfeffer, 1998; Wan et al., 1998). Alternatively, hepa- of the CFTR cytoplasmic tail containing a PDZ domain-
tocytes make use of another yet to be described adap- interacting motif (Moyer et al., 1999). Normally apical,
tor-sorting system. AP-3 complexes are associated with the mutant protein becomes nonpolarized in MDCK
lysosomal transport and thus do not seem likely to fulfill cells, but neither the mechanism of this effect nor its
this role; the ubiquitously expressed AP-4 complex is pathological consequences are understood.
without a clear functional assignment, but is expressed In summary, we have functionally characterized the
at low levels making its involvement in a quantitatively FH-Turku allele of the LDLR and shown that a substitu-
important transport event unlikely (Bonifacino and Dell’ tion of a glycine 34 residue results in a defect in polarized
Angelica, 1999). targeting of the receptor in hepatocytes. This feature is
Our functional data demonstrate that expression of entirely sufficient to generate an FH phenotype. Thus,
the G34D mutant LDLR does not replace wild-type LDLR the mutation affects the signals that specify basolateral
function in transgenic mice. Thus, the decreased LDL targeting within polarized epithelial cells and, as such,
clearance in FH patients harboring the FH-Turku allele provides a genetic proof that work on basolateral tar-
most likely reflects a defect in LDLR polarity. Adenovi- geting using in vitro systems has revealed a physiologi-
rus-mediated expression resulted in the appearance of cally important aspect of epithelial cell polarity.
mutant, but not wild-type, receptor at the bile canalicular
membrane. Nevertheless, a significant amount of mu-
Experimental Procedures
tant LDLR, like the wild-type, was also present at the
sinusoidal surface. The reasons for this were not entirely Plasmids
clear, although it is likely that some of the receptor All transfection constructs were generated and expressed in the
CMV-based eukaryotic expression vector pCB. The cDNA encodingbecomes expressed by sinusoidal endothelial cells
a wild-type LDLR with an additional HindIII site in the membrane-which are also susceptible to adenovirus infection (Yu
spanning domain has been described previously (Hunziker et al.,et al., 2000). Expression of the receptor in these nonpa-
1991). The C-terminal mutants of LDLR were constructed by replac-renchymal cells would not be expected to influence
ing the HindIII/XhoI fragment of the wild-type LDLR plasmid with
plasma cholesterol levels appreciably. fragments generated by PCR using appropriate mutagenic primers.
On the other hand, overexpression of LDLR might The sequences of all primers are available on request. For microin-
cause an increase in the absolute amount of the apically jection experiments, cDNAs encoding wild-type and mutant LDLR
were subcloned in a CMV-based expression vector pRK5. The se-targeted receptor mutant in transient residence at the
quences of all cloned fragments were verified by automated DNAhepatocyte sinusoidal domain. The amount of sinusoidal
sequencing. The VSVGts045-GFP in pRK5 has been described else-LDLR-G34D is apparently insufficient, however, to medi-
where (Kroschewski et al., 1999).ate the endocytosis of enough plasma LDL to affect
whole body cholesterol levels. The situation may be
Recombinant Adenovirusesfurther exacerbated by saturation of the endocytosis
Recombinant adenoviruses encoding C-terminal variants of LDLRor sorting machinery present at the sinusoidal surface
were generated according to the method described by He et al.(Matter et al., 1993; Marmorstein et al., 2000). A similar
(He et al., 1998). The adenovirus encoding the wild-type LDLR was
situation was observed upon expression of the G34D obtained from James Wilson (University of Pennsylvania). The virus
mutant in WIF-B cells. Despite the presence of at least particles for intravenous injections were further purified by CsCl
some receptor at the basolateral surface, little uptake density gradient followed by dialysis against 10% glycerol in PBS
and finally sterilized through 0.22 m filter.of DiI-LDL was observed. In a previous study (Yokode
et al., 1992), a mutant LDLR containing only the first 22
amino acids of the cytoplasmic tail and thus lacking all Cell Culture
basolateral targeting information was found primarily at MDCK (strain II) cells were cultured in DMEM with 10% fetal bovine
serum (FBS) and plated for experiments onto permeable Transwellthe bile canalicular membrane in transgenic mice. Thus,
polycarbonate filters (Corning Costar) at a density of 1  105 cells/under conditions of transgenesis likely to yield far lower
cm2. Stable cell lines were obtained by the calcium phosphate pre-expression levels, and also under conditions when ex-
cipitation method followed by clonal selection with G418 (500 g/
pression was driven by a liver-specific promoter, a ml). WIF-B cells were grown in 7% CO2 in modified Ham’s F12
greater fraction of an apically targeted LDLR appeared medium with HAT (10 mM hypoxanthine, 0.04 mM aminopterin, 1.6
uniquely at the bile front. mM thymidine) containing 5% FBS and plated for experiments on
glass coverslips at a density of 1.3  104 cells/cm2. ExperimentsIn any event, the fact that individuals harboring the FH-
Cell
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